You May Qualify for the Migraine Study If…
• If you are 18 years of age or older
• If you have a history of migraine with or without aura
• If you are currently taking a migraine preventive medication(s) that does not seem effective
The migraine study is evaluating an investigational medication, in combination with a standard of care migraine prevention therapy, for the treatment of migraine. The investigational medication in this study is approved for use in the United States. Data has been collected from other studies indicating that the medication has the potential to reduce the occurrence of migraines and their disruptive outcomes.
All study-related visits, tests, and drugs may be provided at no cost. In addition, reimbursement for study related travel may be provided.
The study will include approximately 9 visits over approximately 30 weeks (24 week treatment period).